Created at	Source	Raw Value	Validated value
Feb. 25, 2022, noon	oms	To evaluate the safety and tolerability after RLS Protein Subunit Vaccine against SARS-CoV-2 Virus <br/ >after administration in healthy volunteers.Timepoint: From Day 0 to Day 56	To evaluate the safety and tolerability after RLS Protein Subunit Vaccine against SARS-CoV-2 Virus <br/ >after administration in healthy volunteers.Timepoint: From Day 0 to Day 56